LIFECORE BIOMEDICAL, INC. Retained Earnings
LIFECORE BIOMEDICAL, INC. (LFCR) had Retained Earnings of -$244.34 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-05
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$244.34M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$238.18M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$223.20M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$218.09M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$244.34M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | -$238.18M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | -$223.20M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | -$218.09M 10-Q · filed 2025-11-06 | |
| 2025-05-25 | -$205.24M 10-KT · filed 2026-03-16 | |
| 2025-02-23 | -$204.09M 10-Q · filed 2025-04-03 | |
| 2024-11-24 | -$191.46M 10-Q · filed 2025-01-02 | |
| 2024-08-25 | -$182.75M 10-Q · filed 2024-10-04 | |
| 2024-05-26 | -$166.52M 10-KT · filed 2026-03-16 | |
| 2024-02-25 | -$159.44M 10-Q · filed 2024-08-09 | |
| 2023-11-26 | -$175.07M 10-Q · filed 2024-08-09 | |
| 2023-08-27 | -$189.29M 10-Q · filed 2024-08-09 | |
| 2023-05-28 | -$178.54M 10-K · filed 2024-08-26 | |
| 2023-02-26 | -$139.25M 10-K · filed 2024-03-20 | -$140.09M 10-Q · filed 2023-06-02 |
| 2022-11-27 | -$102.75M 10-K · filed 2024-03-20 | -$99.90M 10-Q · filed 2023-03-16 |
| 2022-08-28 | -$89.94M 10-K · filed 2024-03-20 | -$70.92M 10-Q · filed 2022-10-07 |
| 2022-05-29 | -$78.97M 10-K · filed 2024-03-20 | -$58.85M 10-K · filed 2022-09-14 |
| 2022-02-27 | -$23.70M 10-K · filed 2024-03-20 | -$22.19M 10-Q · filed 2022-04-07 |
| 2021-11-28 | -$10.12M 10-K · filed 2024-03-20 | -$9.34M 10-Q · filed 2022-01-07 |
| 2021-08-29 | $28.36M 10-K · filed 2024-03-20 | $29.10M 10-Q · filed 2021-10-05 |
| 2021-05-30 | $37.74M 10-K · filed 2024-03-20 | $38.58M 10-K · filed 2021-07-29 |
| 2021-02-28 | $39.02M 10-K · filed 2024-03-20 | $41.45M 10-Q · filed 2021-04-08 |
| 2020-11-29 | $46.00M 10-K · filed 2024-03-20 | $46.94M 10-Q · filed 2021-01-07 |
| 2020-08-30 | $57.63M 10-K · filed 2024-03-20 | $60.24M 10-Q · filed 2020-10-07 |
| 2020-05-31 | $71.25M 10-K · filed 2021-07-29 | |
| 2020-02-23 | $86.39M 10-Q · filed 2020-04-03 | |
| 2019-11-24 | $97.91M 10-Q · filed 2020-01-02 | |
| 2019-08-25 | $104.65M 10-Q · filed 2019-10-03 | |
| 2019-05-26 | $109.71M 10-K · filed 2020-08-14 | |
| 2019-02-24 | $109.97M 10-Q · filed 2019-04-04 | |
| 2018-11-25 | $108.90M 10-Q · filed 2019-01-07 | |
| 2018-08-26 | $109.49M 10-Q · filed 2018-10-05 | |
| 2018-05-27 | $109.30M 10-K · filed 2019-08-01 | |
| 2018-02-25 | $103.19M 10-Q · filed 2018-04-05 | |
| 2017-11-26 | $87.10M 10-Q · filed 2018-01-05 | |
| 2017-08-27 | $86.62M 10-Q · filed 2017-09-28 | |
| 2017-05-28 | $84.47M 10-K · filed 2018-08-09 | |
| 2017-02-26 | $82.02M 10-Q · filed 2017-04-07 | |
| 2016-11-27 | $78.52M 10-Q · filed 2017-01-05 | |
| 2016-08-28 | $77.19M 10-Q · filed 2016-09-29 | |
| 2016-05-29 | $73.46M 10-K/A · filed 2018-03-15 | |
| 2016-02-28 | $68.73M 10-Q · filed 2016-03-30 | |
| 2015-11-29 | $89.92M 10-Q · filed 2016-01-07 | |
| 2015-08-30 | $88.05M 10-Q · filed 2015-10-01 | |
| 2015-05-31 | $85.10M 10-K · filed 2016-08-01 | |
| 2015-03-01 | $80.90M 10-Q · filed 2015-04-02 | |
| 2014-11-30 | $77.13M 10-Q · filed 2015-01-09 | |
| 2014-08-31 | $73.91M 10-Q · filed 2014-10-08 | |
| 2014-05-25 | $71.55M 10-K · filed 2015-07-31 | |
| 2014-02-23 | $67.01M 10-Q · filed 2014-03-28 | |
| 2013-11-24 | $60.61M 10-Q · filed 2014-01-03 | |
| 2013-08-25 | $57.16M 10-Q · filed 2013-09-26 | |
| 2013-05-26 | $52.41M 10-K · filed 2014-08-01 | |
| 2013-02-24 | $47.89M 10-Q · filed 2013-04-04 | |
| 2012-11-25 | $43.10M 10-Q · filed 2013-01-04 | |
| 2012-08-26 | $34.19M 10-Q/A · filed 2013-01-02 | $32.36M 10-Q · filed 2012-10-03 |
| 2012-05-27 | $29.82M 10-K · filed 2013-08-07 | |
| 2012-02-26 | $27.04M 10-Q · filed 2012-03-28 | |
| 2011-11-27 | $22.28M 10-Q · filed 2012-01-05 | |
| 2011-08-28 | $18.94M 10-Q · filed 2011-10-05 | |
| 2011-05-29 | $17.13M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |